Data At ASCO Show Promise Of Novartis Drugs For Patients With Life-Threatening Diseas
 

Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG, announced that nearly 170 abstracts highlighting investigational uses of current therapies and investigational agents in the Novartis Oncology portfolio will be presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) from June 4 through June 8 in Chicago, IL (1)...

More...